Page 72 - Heart Transplant Protocol
P. 72

Heart Function Service: Heart Transplant Protocols

                          o  Acute Demyelinating Encephalomyelitis refractory to PMP
                          o  Rasmussen’s encephalitis
                          o  Progressive seizure disorder which responded to PMP but for medical reasons cannot be
                              used
                     Cardiomyopathy
                          o  Single dose 1000-2000 mg/kg/dose
                          o

               Attachment B

                                                   Administration Protocols

               1. If patient and vital signs are stable, administration rate may be increased as follows:


                                                   IVIG Administration Rate

               If using a 10% solution:
                             Time               Initial Infusion/Reduced Rate*         Infusion Rate
                 Initial infusion rate          (0.025 g/kg/hour) 0.25         (0.05 g/kg/hour) 0.5
                                                mL/kg/hour                     mL/kg/hour

                 After 15-30 minutes at previous  (0.05 g/kg/hour) 0.5 mL/kg/hour  (0.1 g/kg/hour) 1 mL/kg/hour
                 rate, may increase to
                 After 15-30 minutes at previous  (0.1 g/kg/hour) 1 mL/kg/hour   (0.2 g/kg/hour) 2 mL/kg/hour
                 rate, may increase to
                 After 15-30 minutes at previous  (0.2 g/kg/hour) 2 mL/kg/hour   (0.4 g/kg/hour) 4 mL/kg/hour
                 rate, may increase to
                 Maximum Infusion Rate          (0.2 g/kg/hour) 2 mL/kg/hour   (0.4 g/kg/hour) 4 mL/kg/hour

               *Consider reduced infusion rate if patient is at risk for renal insufficiency, thromboembolic events,
               volume overload, and/or utilizing 10% solution for initial dose.

               2. Lower to previous infusion rate if patient develops:


                     Headache
                     Fever/chills
                     Nausea/vomiting
                     Flushing
                     Pruritus
                     Lightheadedness
                     Myalgia or
                     Fatigue

                   If patient symptoms persist, notify prescriber, lower infusion rate further or stop infusions as
                   ordered until symptoms resolve.







               Updated November 9, 2017                                                                    72
   67   68   69   70   71   72   73   74   75   76   77